Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
2.022
+0.022 (1.11%)
May 19, 2025, 11:04 AM - Market open
Cyclacel Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 3.45 | 3.14 | 3.38 | 18.35 | 36.56 | 33.41 | Upgrade
|
| Cash & Short-Term Investments | 3.45 | 3.14 | 3.38 | 18.35 | 36.56 | 33.41 | Upgrade
|
| Cash Growth | 23.30% | -7.13% | -81.59% | -49.82% | 9.44% | 181.08% | Upgrade
|
| Other Receivables | - | - | 2.93 | 4.66 | 3.73 | 1.31 | Upgrade
|
| Receivables | - | - | 2.93 | 4.66 | 3.73 | 1.31 | Upgrade
|
| Prepaid Expenses | 0.26 | 0.24 | 0.79 | 0.98 | 0.58 | 0.68 | Upgrade
|
| Other Current Assets | - | 0.3 | 0.34 | 0.43 | 0.08 | 0.07 | Upgrade
|
| Total Current Assets | 3.71 | 3.67 | 7.44 | 24.41 | 40.94 | 35.47 | Upgrade
|
| Property, Plant & Equipment | 0.02 | 0.01 | 0.1 | 0.17 | 0.09 | 1.33 | Upgrade
|
| Other Long-Term Assets | - | 0.41 | 1.26 | 3.47 | 2.1 | - | Upgrade
|
| Total Assets | 3.73 | 4.09 | 8.81 | 28.05 | 43.14 | 36.8 | Upgrade
|
| Accounts Payable | 0.11 | 4.6 | 3.54 | 2.56 | 2.12 | 0.51 | Upgrade
|
| Accrued Expenses | 0.55 | 1.39 | 4.24 | 4.62 | 3.04 | 1.11 | Upgrade
|
| Other Current Liabilities | - | 0.28 | 0.38 | 0.33 | 0.26 | 0.87 | Upgrade
|
| Total Current Liabilities | 0.66 | 6.27 | 8.16 | 7.51 | 5.41 | 2.49 | Upgrade
|
| Long-Term Leases | 0.01 | - | 0.04 | 0.11 | 0.03 | 1.06 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 4.49 | - | - | Upgrade
|
| Total Liabilities | 0.67 | 6.27 | 8.2 | 12.11 | 5.44 | 3.54 | Upgrade
|
| Common Stock | 0.2 | 0.01 | 0 | 0 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 443.32 | 438.2 | 429.8 | 422.98 | 422.96 | 400.07 | Upgrade
|
| Retained Earnings | -440.46 | -439.49 | -428.28 | -405.73 | -384.53 | -366.07 | Upgrade
|
| Comprehensive Income & Other | 0 | -0.89 | -0.91 | -1.32 | -0.75 | -0.75 | Upgrade
|
| Shareholders' Equity | 3.06 | -2.17 | 0.61 | 15.94 | 37.69 | 33.26 | Upgrade
|
| Total Liabilities & Equity | 3.73 | 4.09 | 8.81 | 28.05 | 43.14 | 36.8 | Upgrade
|
| Total Debt | 0.01 | - | 0.04 | 0.11 | 0.03 | 1.06 | Upgrade
|
| Net Cash (Debt) | 3.44 | 3.14 | 3.34 | 18.24 | 36.53 | 32.35 | Upgrade
|
| Net Cash Growth | 23.91% | -6.11% | -81.68% | -50.07% | 12.92% | 202.50% | Upgrade
|
| Net Cash Per Share | 0.02 | 9.37 | 62.83 | 388.90 | 982.17 | 2136.80 | Upgrade
|
| Filing Date Shares Outstanding | 356.36 | 12.96 | 0.08 | 0.05 | 0.04 | 0.03 | Upgrade
|
| Total Common Shares Outstanding | 207.34 | 0.55 | 0.07 | 0.05 | 0.04 | 0.03 | Upgrade
|
| Working Capital | 3.05 | -2.59 | -0.72 | 16.9 | 35.53 | 32.98 | Upgrade
|
| Book Value Per Share | 0.01 | -3.93 | 9.17 | 305.07 | 905.25 | 1277.77 | Upgrade
|
| Tangible Book Value | 3.06 | -2.17 | 0.61 | 15.94 | 37.69 | 33.26 | Upgrade
|
| Tangible Book Value Per Share | 0.01 | -3.93 | 9.17 | 305.07 | 905.25 | 1277.77 | Upgrade
|
| Machinery | - | 0.42 | 0.42 | 0.41 | 0.42 | 0.58 | Upgrade
|
| Leasehold Improvements | - | 0.01 | 0.01 | 0.01 | 0.01 | 0.41 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.